SKI Market

A+| A| A-|

Indian Indices

Sensex

77,054.94 -561.46
( -0.72%)

Global Indices

Nasdaq

52,540.76 21.12
(0.04%)

Dow Jones

7,564.35 28.01
(0.37%)

Hang Seng

67,669.68 426.95
(0.63%)

Nikkei 225

10,519.19 20.90
(0.20%)

Forex

USD-INR

95.25 -0.20
(-0.21%)

EUR-INR

108.70 -0.40
(-0.37%)

GBP-INR

127.58 -0.36
(-0.28%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

41.3428411

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

16.85

1174.31

EPS(TTM)

Face Value()

Div & Yield %

19.95

Back

Nimbus Projects reports consolidated net loss of Rs 40.95 crore in the December 2025 quarter

Feb 11,2026

Net loss of Nimbus Projects reported to Rs 40.95 crore in the quarter ended December 2025 as against net profit of Rs 53.48 crore during the previous quarter ended December 2024. Sales rose 3.20% to Rs 2.26 crore in the quarter ended December 2025 as against Rs 2.19 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.26	2.19	3
OPM %	-1034.51	4948.40	-
PBDT	-42.94	71.73	PL
PBT	-43.41	71.48	PL
NP	-40.95	53.48	PL

77,054.94 -561.46 ( -0.72%)

52,540.76 21.12 (0.04%)

7,564.35 28.01 (0.37%)

67,669.68 426.95 (0.63%)

10,519.19 20.90 (0.20%)

95.25 -0.20 (-0.21%)

108.70 -0.40 (-0.37%)

127.58 -0.36 (-0.28%)

0.59 0.00 (0.19%)